6 Paul Tudor Jones II Northwest Biotherapeutics Trades
The first Northwest Biotherapeutics trade was made in Q1 2015. Since then Paul Tudor Jones II bought shares three more times and sold shares on two occasions. The investor sold all their shares in Q1 2017 and doesn't own any shares in Northwest Biotherapeutics anymore.
Avg closing price
Price range
Sold -31.7 Thousand shares
Q1 2017
Avg closing price
$0.37
Price range
$0.23
-
$0.48
Increased shares by 1.9% (+600 shares)
Q1 2016
Avg closing price
-
Price range
-
-
-
Increased shares by 13.6% (+3.72 Thousand shares)
Q4 2015
Avg closing price
-
Price range
-
-
-
Increased shares by 34.9% (+7.07 Thousand shares)
Q3 2015
Avg closing price
-
Price range
-
-
-
Sold 10.0% shares (-2.25 Thousand shares)
Q2 2015
Avg closing price
-
Price range
-
-
-
New holding (+22.5 Thousand shares)
Q1 2015
Avg closing price
-
Price range
-
-
-
